Asset Allocation
| Position | Category/Sector | Target Weight |
|---|---|---|
BNTX BioNTech SE | Healthcare | 16.67% |
MRNA Moderna, Inc. | Healthcare | 16.67% |
NVAX Novavax, Inc. | Healthcare | 16.67% |
NVO Novo Nordisk A/S | Healthcare | 16.67% |
PFE Pfizer Inc. | Healthcare | 16.67% |
VKTX Viking Therapeutics, Inc. | Healthcare | 16.67% |
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in sheep special, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.
Loading graphics...
The earliest data available for this chart is Oct 10, 2019, corresponding to the inception date of BNTX
Returns By Period
| 1D | 1M | YTD | 6M | 1Y | 3Y* | 5Y* | 10Y* | |
|---|---|---|---|---|---|---|---|---|
Benchmark S&P 500 Index | 0.11% | -3.43% | -3.84% | -1.98% | 16.08% | 16.86% | 10.37% | 12.29% |
Portfolio sheep special | 0.50% | -2.14% | 11.91% | 6.67% | 21.09% | 7.47% | 10.12% | — |
| Portfolio components: | ||||||||
VKTX Viking Therapeutics, Inc. | 5.58% | 8.99% | -1.08% | 24.82% | 35.51% | 25.58% | 40.84% | 37.04% |
NVO Novo Nordisk A/S | 1.37% | 4.40% | -24.78% | -34.84% | -43.28% | -20.60% | 3.97% | 5.03% |
NVAX Novavax, Inc. | -3.99% | -18.86% | 14.58% | -19.37% | 28.76% | 1.33% | -47.10% | -23.09% |
BNTX BioNTech SE | 1.97% | -9.51% | -4.22% | -12.75% | -2.29% | -11.04% | -3.91% | — |
PFE Pfizer Inc. | -0.81% | 6.55% | 15.64% | 8.20% | 22.98% | -6.37% | 0.03% | 4.18% |
MRNA Moderna, Inc. | -1.66% | -1.26% | 66.84% | 73.42% | 77.49% | -32.43% | -17.98% | — |
Monthly Returns
Based on dividend-adjusted daily data since Oct 11, 2019, sheep special's average daily return is +0.19%, while the average monthly return is +4.09%. At this rate, your investment would double in approximately 1.4 years.
Historically, 56% of months were positive and 44% were negative. The best month was Feb 2024 with a return of +46.6%, while the worst month was Jan 2022 at -23.4%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 6 months.
On a daily basis, sheep special closed higher 50% of trading days. The best single day was Feb 27, 2024 with a return of +35.4%, while the worst single day was Mar 9, 2020 at -13.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 17.85% | 3.19% | -8.42% | 0.48% | 11.91% | ||||||||
| 2025 | -1.25% | -6.39% | -16.06% | 4.95% | -1.34% | -0.33% | 0.38% | -2.37% | 3.81% | 6.35% | -3.05% | -0.75% | -16.64% |
| 2024 | 1.76% | 46.60% | 6.17% | -3.41% | 45.35% | -11.49% | 3.40% | -3.55% | 2.56% | -6.62% | -10.97% | -9.47% | 51.52% |
| 2023 | -2.86% | -4.73% | 11.15% | 2.62% | -1.09% | -7.52% | 1.66% | 0.08% | -9.01% | -10.35% | 3.74% | 12.60% | -6.39% |
| 2022 | -23.41% | -7.93% | 4.22% | -17.09% | 6.94% | 1.58% | 6.15% | -13.99% | -12.77% | 19.59% | 4.98% | 22.48% | -18.96% |
| 2021 | 38.38% | -3.90% | -8.79% | 26.55% | -5.28% | 16.02% | 17.42% | 9.11% | -7.14% | -4.67% | 12.30% | -13.61% | 85.61% |
Benchmark Metrics
sheep special has an annualized alpha of 43.97%, beta of 0.83, and R² of 0.12 versus S&P 500 Index. Calculated based on daily prices since October 11, 2019.
- This portfolio captured 167.94% of S&P 500 Index gains but only 52.80% of its losses — a favorable profile for investors.
- R² of 0.12 means this portfolio moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 43.97%
- Beta
- 0.83
- R²
- 0.12
- Upside Capture
- 167.94%
- Downside Capture
- 52.80%
Expense Ratio
sheep special has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.
Return for Risk
Risk / Return Rank
sheep special ranks 13 for risk / return — in the bottom 13% of portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
| Portfolio | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.52 | 0.88 | -0.37 |
Sortino ratioReturn per unit of downside risk | 0.98 | 1.37 | -0.38 |
Omega ratioGain probability vs. loss probability | 1.12 | 1.21 | -0.09 |
Calmar ratioReturn relative to maximum drawdown | 1.32 | 1.39 | -0.07 |
Martin ratioReturn relative to average drawdown | 2.59 | 6.43 | -3.85 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.
| Risk / Return Rank | Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Martin ratio | |
|---|---|---|---|---|---|---|
VKTX Viking Therapeutics, Inc. | 59 | 0.46 | 1.11 | 1.17 | 1.01 | 2.23 |
NVO Novo Nordisk A/S | 11 | -0.80 | -0.97 | 0.87 | -0.78 | -1.35 |
NVAX Novavax, Inc. | 56 | 0.38 | 1.16 | 1.13 | 0.79 | 1.66 |
BNTX BioNTech SE | 38 | -0.05 | 0.29 | 1.04 | 0.03 | 0.06 |
PFE Pfizer Inc. | 68 | 0.87 | 1.38 | 1.17 | 1.89 | 4.26 |
MRNA Moderna, Inc. | 75 | 1.18 | 1.93 | 1.23 | 2.29 | 4.71 |
Loading graphics...
Dividends
Dividend yield
sheep special provided a 1.82% dividend yield over the last twelve months.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portfolio | 1.82% | 1.70% | 1.34% | 1.12% | 1.12% | 0.66% | 0.96% | 0.97% | 0.76% | 0.84% | 1.09% | 0.73% |
| Portfolio components: | ||||||||||||
VKTX Viking Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 4.87% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
NVAX Novavax, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BNTX BioNTech SE | 0.00% | 0.00% | 0.00% | 0.00% | 2.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 6.07% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
MRNA Moderna, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the sheep special. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the sheep special was 59.74%, occurring on Sep 26, 2022. Recovery took 408 trading sessions.
The current sheep special drawdown is 45.55%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -59.74% | Aug 10, 2021 | 285 | Sep 26, 2022 | 408 | May 10, 2024 | 693 |
| -59.54% | Jun 6, 2024 | 212 | Apr 10, 2025 | — | — | — |
| -30.24% | Feb 9, 2021 | 19 | Mar 8, 2021 | 63 | Jun 7, 2021 | 82 |
| -28.86% | Mar 2, 2020 | 11 | Mar 16, 2020 | 2 | Mar 18, 2020 | 13 |
| -27.05% | Jul 23, 2020 | 33 | Sep 8, 2020 | 57 | Nov 27, 2020 | 90 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Diversification
Diversification Metrics
Number of Effective Assets
The portfolio contains 6 assets, with an effective number of assets of 6.00, reflecting the diversification based on asset allocation. This number of effective assets indicates a moderate level of diversification, where some assets may have a more significant influence on overall performance.
Asset Correlations Table
| Benchmark | NVO | PFE | VKTX | NVAX | BNTX | MRNA | Portfolio | |
|---|---|---|---|---|---|---|---|---|
| Benchmark | 1.00 | 0.36 | 0.32 | 0.37 | 0.30 | 0.31 | 0.31 | 0.40 |
| NVO | 0.36 | 1.00 | 0.28 | 0.27 | 0.18 | 0.22 | 0.20 | 0.37 |
| PFE | 0.32 | 0.28 | 1.00 | 0.19 | 0.23 | 0.35 | 0.31 | 0.42 |
| VKTX | 0.37 | 0.27 | 0.19 | 1.00 | 0.28 | 0.23 | 0.27 | 0.55 |
| NVAX | 0.30 | 0.18 | 0.23 | 0.28 | 1.00 | 0.41 | 0.52 | 0.76 |
| BNTX | 0.31 | 0.22 | 0.35 | 0.23 | 0.41 | 1.00 | 0.56 | 0.68 |
| MRNA | 0.31 | 0.20 | 0.31 | 0.27 | 0.52 | 0.56 | 1.00 | 0.71 |
| Portfolio | 0.40 | 0.37 | 0.42 | 0.55 | 0.76 | 0.68 | 0.71 | 1.00 |